C

CVS Health

Runs pharmacies, health plans and clinics

Sales Vice President - National Accounts

Full-TimeDeadline 11/3/26
$60.4k - $126.6k
Senior, Expert
Bachelor's
Texas, USA
In Person
Sales & Account ManagementAccount Executive
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • Five to ten or more years of healthcare industry sales, account management, and/or consulting experience, focused on group insurance.
  • Proven success managing large, geographically dispersed accounts.
  • Client-facing and presentation experience across finalist and capabilities meetings.
  • Deep understanding of business financials, products, services, group underwriting, market trends, and the competitive landscape.
  • Proficiency in Microsoft Office and Salesforce.
  • Experience managing the request for proposal process with cross-functional teams, including underwriting, legal, actuarial, and marketing, to develop compelling and compliant submissions.
  • An active Health and Life license is required; it may be obtained within 90 days of hire in exception-based circumstances.
  • A bachelor's degree or equivalent work experience.
Responsibilities
  • Develop and execute a sales strategy and process that achieves membership growth beyond the assigned target.
  • Execute prospecting initiatives and lead generation.
  • Conduct consultant meetings and briefings.
  • Qualify request for proposal opportunities through consultant debriefs, network analysis, and identifying a path to winning.
  • Execute financial strategy by making intentional recommendations based on an understanding of how Aetna is evaluated.
  • Lead finalist meetings with sophisticated client audiences, including C-suite members.
  • Identify opportunities in the assigned territory and build a multi-year prospect pipeline using the full range of product lines to address clients' needs and benefits.
  • Manage and build producer relations as needed for the book of business or supported market segments.
  • Coordinate sales materials, testimonials, and subject matter expert participation for constituent presentations.
  • Lead or facilitate finalist presentations, educational presentations, consultant briefings, and capabilities presentations for National Account audiences.
  • Deliver organized presentations of solutions with benefits tied to constituents' needs.
  • Collaborate with underwriting to prepare competitive quotes for targeted prospects, considering Aetna's profit, revenue, and margin expectations.
  • Monitor industry information and the competitive marketplace to position Aetna's strengths.
Desired Qualifications
  • Previous experience within National Accounts.
  • An established network of brokers, consultants, and employer contacts.

About the company

CVS Health runs pharmacies, health insurance plans and medical clinics for individuals, employers and government programs across the United States. Its businesses include CVS Pharmacy, the Aetna insurer and Caremark, which manages prescription coverage and negotiates drug prices for health plans. Patients fill prescriptions in stores or by mail and receive care through walk-in clinics, primary care centers and home visits. The company earns money from prescription sales, insurance premiums, plan administration fees and clinical services, combining coverage with places to obtain treatment. Its first store opened in 1963, and its headquarters are in Woonsocket, Rhode Island.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand is expanding: CVS Health reported $106.1 billion revenue in the June 2026 quarter, up 7.3% year over year.
  • Eligible colleagues get degree support: CVS Health's partner-college program covers tuition with no out-of-pocket cost through reimbursement.
  • Self-pay care is expanding: MinuteClinic announced $29 online weight-loss visits in August 2026, without recurring membership fees.

What critics are saying

  • Insurance leaves a narrow cushion: Aetna's medical costs consumed 87.4% of premium revenue in the June 2026 quarter.
  • Drug fees face limits: Caremark's July 2026 FTC settlement proposes separating fees from drug list prices.
  • Wilmington's pharmacist role includes mobility: CVS Rx Services lists up to 25% travel across nearby pharmacy locations.

What makes CVS Health unique

  • Its pharmacy shelves are tobacco-free: CVS removed tobacco products while keeping its national retail pharmacy network.
  • Caremark separates drug costs from service fees: TrueCost anchors pricing to acquisition benchmarks and makes dispensing fees visible.
  • Its clinics accept care-cost risk: Oak Street receives fixed payments from health plans rather than billing only per visit.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

PR Newswire
Oct 7th, 2026
CVS Health opens first pharmacy-focused location in Boston area

CVS Health has opened its first pharmacy-focused location in the Boston area, situated at 32 Warren Street in Roxbury. The company plans to launch nearly 20 such locations across the US in 2026 to increase access to pharmacy care. The new format features full-service pharmacies averaging 3,000 square feet, offering prescription medications, immunisations, and over-the-counter products. Customers can order additional items with free home delivery. The Roxbury site includes a medication disposal bin and safe needle collection point. These smaller pharmacies complement CVS's existing formats, including traditional stores, store-in-store locations in Target and Schnucks, and sites with MinuteClinic facilities. According to CVS Health's 2025 Rx Report, 80% of patients prefer face-to-face pharmacy care, whilst 48% would switch pharmacies if limited to digital-only options.

Yahoo Finance
Sep 25th, 2026
CVS shares drop 15% as pharmacy giant warns of unquantified 340B business headwinds in 2027

CVS Health faces an unquantified headwind from its 340B drug discount programme heading into 2027, management warned during its fiscal Q2 2026 earnings call in August. The company's shares have fallen 15.2% over the past three months, even as management raised its 2026 earnings outlook. The 340B business, which serves eligible healthcare organisations, is experiencing pressure as drugmakers limit programme coverage. Management expects this drag to continue affecting its pharmacy services business in 2027 but declined to quantify the potential impact. CVS's Health Services segment, which likely includes the 340B business, generated $190.4 billion in revenue during fiscal 2025. The company trades at 22.5 times trailing earnings, roughly level with the S&P 500's 22.4 multiple.

Yahoo Finance
Sep 18th, 2026
CVS Omnicare completes $250M bankruptcy sale after $440M government settlement

CVS Health's Omnicare division has completed its Chapter 11 bankruptcy liquidation after selling its business operations for $250 million. A Texas bankruptcy judge approved the wind-down plan following a $440 million settlement with the Justice Department over improper billing practices. Omnicare, which served nursing homes and long-term care facilities, filed for bankruptcy in September 2025 after facing a $949 million judgement for fraudulently dispensing drugs without valid prescriptions and billing federal healthcare programmes for false claims. The settlement requires CVS to pay $130 million upfront and cover the remaining $310 million if Omnicare fails to do so by March 2028. GenieRx Holdings, a joint partnership between Milrose Capital and Integro Asset Management, purchased Omnicare's operations. The sale is expected to close next month.

Yahoo Finance
Sep 14th, 2026
CVS Health up 32% in a year: is it time to buy the stock?

CVS Health shares have declined 2.1% over the past three months, prompting investors to consider whether now is an opportune time to buy. The healthcare giant, which operates approximately 9,000 retail pharmacy locations and serves more than 35 million people through its health insurance business, reported second-quarter revenue of $106 billion, up 7.3% year-over-year. Adjusted earnings per share rose 43% in the same period. The company offers a dividend yield of 2.8%, with its annual payout increasing from $2 in 2021 to $2.66 per share recently. Shares currently trade at $95, with one analyst setting a price target of $120. The stock's forward price-to-earnings ratio of 11 sits slightly above its five-year average of 10.

Yahoo Finance
Sep 13th, 2026
US health insurers rebound as medical costs stabilise, analysts predict 16% earnings growth through 2030

The health insurance industry may have recovered from high medical costs, with analysts predicting strong growth through 2030. Morningstar forecasts 16% annual earnings per share growth for major insurers, above the industry's typical low-double-digit target. Health insurers are improving profitability by raising rates to cover increased medical utilisation. UnitedHealth Group reported over $5 billion in second-quarter net income, with its medical care ratio falling to 86.7% from 89.4% year-over-year. The outlook also improved for pharmacy benefit management operations at companies like UnitedHealth, CVS Health, and Cigna. Despite increased regulatory scrutiny, the "big three" PBMs maintain strong competitive positions. Third-quarter earnings reports next month should provide further clarity on the industry's financial health.